The burden of uterine fibroids for African-American women: results of a national survey
- PMID: 24033092
- PMCID: PMC3787340
- DOI: 10.1089/jwh.2013.4334
The burden of uterine fibroids for African-American women: results of a national survey
Abstract
Background: Uterine fibroids have a disproportionate impact on African-American women. There are, however, no data to compare racial differences in symptoms, quality of life, effect on employment, and information-seeking behavior for this disease.
Methods: An online survey was conducted by Harris Interactive between December 1, 2011 and January 16, 2012. Participants were U.S. women aged 29-59 with symptomatic uterine fibroids. African-American women were oversampled to allow statistical comparison of this high-risk group. Bivariate comparison of continuous and categorical measures was based on the t-test and the Chi-squared test, respectively. Multivariable adjustment of risk ratios was based on log binomial regression.
Results: The survey was completed by 268 African-American and 573 white women. There were no differences between groups in education, employment status, or overall health status. African-American women were significantly more likely to have severe or very severe symptoms, including heavy or prolonged menses (RR=1.51, 95% CI 1.05-2.18) and anemia (RR=2.73, 95% CI 1.47-5.09). They also more often reported that fibroids interfered with physical activities (RR=1.67, 95% CI 1.20-2.32) and relationships (RR=2.27, 95% CI 1.23-4.22) and were more likely to miss days from work (RR=1.77, 95% CI 1.20-2.61). African-American women were more likely to consult friends and family (36 vs. 22%, P=0.004) and health brochures (32 vs. 18%, P<0.001) for health information. Concerns for future fertility (RR=2.65, 95% CI 1.93-3.63) and pregnancy (RR=2.89, 95% CI 2.11-3.97) following fibroid treatments were key concerns for black women.
Conclusions: African-American women have more severe symptoms, unique concerns, and different information-seeking behavior for fibroids.
Comment in
-
Uterine fibroid: the burden borne by African American women.J Womens Health (Larchmt). 2013 Oct;22(10):793-4. doi: 10.1089/jwh.2013.4597. J Womens Health (Larchmt). 2013. PMID: 24079936 No abstract available.
Similar articles
-
Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.Fertil Steril. 2013 Mar 1;99(3):768-776.e1. doi: 10.1016/j.fertnstert.2012.10.039. Epub 2012 Nov 27. Fertil Steril. 2013. PMID: 23199610 Free PMC article.
-
Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health.J Psychosom Res. 2015 May;78(5):499-503. doi: 10.1016/j.jpsychores.2014.12.016. Epub 2015 Feb 2. J Psychosom Res. 2015. PMID: 25725565
-
Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study.Environ Health Perspect. 2012 Mar;120(3):406-12. doi: 10.1289/ehp.1103620. Epub 2011 Nov 2. Environ Health Perspect. 2012. PMID: 22049383 Free PMC article.
-
An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.J Womens Health (Larchmt). 2016 Aug;25(8):846-52. doi: 10.1089/jwh.2015.5531. Epub 2016 May 19. J Womens Health (Larchmt). 2016. PMID: 27195902 Free PMC article.
-
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2. Cochrane Database Syst Rev. 2017. PMID: 28444736 Free PMC article. Review.
Cited by
-
Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.F S Rep. 2024 Jun 14;5(3):285-295. doi: 10.1016/j.xfre.2024.06.002. eCollection 2024 Sep. F S Rep. 2024. PMID: 39381651 Free PMC article.
-
Symptomatic Calcified Uterine Fibroids Refractory to Repeat Uterine Artery Embolization: A Case Report.Cureus. 2024 May 25;16(5):e61081. doi: 10.7759/cureus.61081. eCollection 2024 May. Cureus. 2024. PMID: 38919206 Free PMC article.
-
Racial Disparities in Medical Management of Uterine Fibroids Prior to Myomectomy or Hysterectomy.J Racial Ethn Health Disparities. 2024 Jun 17. doi: 10.1007/s40615-024-02048-3. Online ahead of print. J Racial Ethn Health Disparities. 2024. PMID: 38886279
-
Data-driven analyses to quantify information seeking behaviour for women with uterine fibroids.Health Syst (Basingstoke). 2022 Dec 19;13(2):73-96. doi: 10.1080/20476965.2022.2150570. eCollection 2024. Health Syst (Basingstoke). 2022. PMID: 38800604 Free PMC article.
-
Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women.PLoS One. 2024 May 23;19(5):e0303823. doi: 10.1371/journal.pone.0303823. eCollection 2024. PLoS One. 2024. PMID: 38781223 Free PMC article.
References
-
- Carlson KJ. Nichols DH. Schiff I. Indications for hysterectomy. N Engl J Med. 1993;328:856–860. - PubMed
-
- Baird DD. Dunson DB. Hill MC. Cousins D. Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107. - PubMed
-
- Walker CL. Stewart EA. Uterine fibroids: The elephant in the room. Science. 2005;308:1589–1592. - PubMed
-
- Marshall LM. Spiegelman D. Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age, race. Obstet Gynecol. 1997;90:967–973. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
